Please note that purchasing this product you agree to our TERMS AND CONDITIONS, DELIVERY AND RETURN POLICY and our PRIVACY POLICY.
Equilis Prequenza (Single) / Prequenza-TE (Single)
From R 251.62
- Prequenza
- Prequenza-TE
- CapeCross
Indicated for the active immunisation of healthy horses and ponies against equine influenza to reduce severity and duration of clinical signs and to reduce the amount and duration of viral shedding after infection
Equilis Prequenza
COMPOSITION:
EQUILIS® PREQUENZA is a vaccine suspension containing per 1ml:
• Purified haemagglutinin/neuraminidase subunits from equine influenza viruses:
- A/equine-1/Prague/1/56 100 AU*
- A/equine-2/Newmarket/1/93 50 AU
- A/equine-2/Newmarket/2/93 50 AU
• Purified saponin (adjuvant) 375 μg
*antigenic units
WARNINGS:
Vaccinate healthy animals only. A transient swelling may occur after vaccination regressing within 2 days. In some cases fever may occur after vaccination. Avoid intravenous injection.
DOSAGE:
Intramuscular injection of one dose (1 ml) per anima
VACCINATION SCHEDULE:
Basic Vaccination course: All horses not previously vaccinated should receive two vaccinations of one dose with a four week interval. Foals should be vaccinated from the age of six months.
Revaccination: The first revaccination (third dose) is given five months after the basic vaccination course. Revaccination, at 12 month intervals is recommended to maintain immunity levels against equine influenza. Local regulations should be adhered to.
PREGNANCY AND LACTATION:
Can be used in pregnant mares
PRESENTATION:
10 x 1 ml pre-filled syringe with peel-off labels
Equilis Prequenza-TE
For the active immunisation of healthy horses and ponies against equine influenza
INDICATIONS: It reduces the severity and duration of clinical signs and reduces the amount and duration of viral shedding after infection. It is also indicated for the active
immunisation against tetanus to prevent disease and mortality.
COMPOSITION:
EQUILIS® PREQUENZA-TE is a vaccine suspension containing per 1ml:
• Purified haemagglutinin/neuraminidase subunits from equine influenza viruses:
- A/equine-1/Prague/1/56 100 AU*
- A/equine-2/Newmarket/1/93 50 AU
- A/equine-2/Newmarket/2/93 50 AU
• Tetanus toxoid 40 Lf**
• Purified saponin (adjuvant) 375 μg
*antigenic units **flocculation units
WARNINGS:
Vaccinate healthy animals only. A transient swelling may occur after vaccination regressing within 2 days. In some cases fever may occur after vaccination. Avoid intravenous injection.
DOSAGE:
Intramuscular injection of one dose (1 ml) per animal.
VACCINATION SCHEDULE
Influenza - Basic vaccination course: All horses not previously vaccinated should receive two vaccinations of one dose with a four week interval. Foals should be vaccinated from the age of six months.
Tetanus - Basic vaccination course: All horses not previously vaccinated should receive two vaccinations of one dose with a four week interval. The first revaccination for tetanus can be given 17 months after the basic vaccination course. Can be used in pregnant
mares.
PRESENTATION
10 x 1 ml pre-filled syringes with peel-off labels